Publications

Filter Publications By:

Binimetinib and Encorafenib

11/09/2016

2016 Society for Melanoma Research (SMR) Annual Congress

Results of COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant Melanoma

Keith T. Flaherty, M.D., et al.

Binimetinib / Cancer

11/07/2016

2016 Society for Melanoma Research (SMR) Annual Congress

Management of MEK inhibitor (MEKi) toxicities of binimetinib (BINI) in the NEMO trial

Paolo A. Ascierto, M.D., et al.

Binimetinib / Cancer

11/07/2016

2016 Society for Melanoma Research (SMR) Annual Congress

Efficacy of binimetinib in patients with NRAS-mutant melanoma: subgroup analysis of the phase 3 NEMO study

Ana Arance, M.D., et al.

ARRY-797 / LMNA DCM

08/31/2016

European Society of Cardiology Congress 2016

Phase 2 Study of A797, an Oral, Selective p38 Mitogen-Activated Protein Kinase Inhibitor, in Patients With Lamin A/C–Related Dilated Cardiomyopathy

Calum A. MacRae, M.D., Ph.D. et al.

Filanesib / Multiple Myeloma

07/19/2016

PubMed.gov

A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.

Chari A., et al.

Encorafenib / Cancer

07/01/2016

ESMO World Congress of Gastrointestinal Cancer

Combination of Encorafenib and Cetuximab With or Without Alpelisib in Patients With Advanced BRAF-Mutant (BRAFm) Colorectal Cancer: Phase 2 Results

J. Tabernero, et al.

Binimetinib / Cancer

06/06/2016

American Society of Clinical Oncology Meeting

Results of NEMO: A phase III trial of binimetinib (BINI) vs dacarbazine (DTIC) in NRAS-mutant cutaneous melanoma

R. Dummer, et al.

Encorafenib / Cancer

06/01/2016

American Society of Clinical Oncology Meeting

Phase 2 results: encorafenib (ENCO) and cetuximab (CETUX) with or without alpelisib (ALP) in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC)

J. Tabernero, et al.

Binimetinib / Cancer

01/21/2016

American Society of Clinical Oncology GI 2016

A Phase I Study of MEK162 and FOLFOX in chemotherapy-resistant metastatic colorectal cancer

M. Cho, et al.

Filanesib / Multiple Myeloma

12/07/2015

American Society of Hematology Annual Meeting 2015

Phase 2 Study of Carfilzomib With or Without Filanesib in Patients With Advanced Multiple Myeloma (MM)

J. Zonder, et al.